These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 4182414)

  • 1. Local application of thymoxamine in peripheral vascular disease.
    Turner P; Harrison J; Schoenfeldt R
    Lancet; 1969 Jun; 1(7608):1238-9. PubMed ID: 4182414
    [No Abstract]   [Full Text] [Related]  

  • 2. [Testosterone and the prostate gland].
    Winther O
    Nord Med; 1970 May; 83(20):624-6. PubMed ID: 5426430
    [No Abstract]   [Full Text] [Related]  

  • 3. [Arterial insufficiency in the lower extremities treated with drugs].
    Genster HG; Oram V
    Ugeskr Laeger; 1971 Feb; 133(6):244-6. PubMed ID: 4926100
    [No Abstract]   [Full Text] [Related]  

  • 4. [Effect of 1-(4-oxyphenyl)-1-oxy-2-n-butylaminoethane sulfate on peripheral vascular diseases].
    Giulini SM; Agus GB; De Cristoforo A
    Minerva Cardioangiol; 1973 Jun; 21(6):434-8. PubMed ID: 4146376
    [No Abstract]   [Full Text] [Related]  

  • 5. [Treatment of some vascular diseases with the use of oxyphenyl-oxybutylamino-ethanol].
    Berezovsky M; Berstein S
    Prensa Med Argent; 1966 Sep; 53(36):1964-71. PubMed ID: 4384691
    [No Abstract]   [Full Text] [Related]  

  • 6. Effect of ticlopidine on the cutaneous circulation in peripheral vascular disease.
    Qian S; Iwai T
    Angiology; 1993 Aug; 44(8):627-31. PubMed ID: 8342879
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [On conserative treatment of arterial circulation disorders].
    Hänel W
    Ther Ggw; 1968 Apr; 107(4):546-8. PubMed ID: 5672326
    [No Abstract]   [Full Text] [Related]  

  • 8. Testosterone and fibrinolytic activity.
    Winther O
    Scand J Clin Lab Invest Suppl; 1967; 99():207-10. PubMed ID: 6060734
    [No Abstract]   [Full Text] [Related]  

  • 9. [Effect of Inderal on intermittent claudication in patients with obliterative arterial disease].
    Skawiński S; Wójcikiewicz O; Peiker W
    Pol Tyg Lek; 1971 Dec; 26(52):2019-21. PubMed ID: 5139589
    [No Abstract]   [Full Text] [Related]  

  • 10. [Intermittent claudication: topical treatment with isosorbide dinitrate ointment. Preliminary results].
    Biagini A; Carpeggiani C; Testa R; Mazzei MG; Michelassi C; L'Abbate A
    G Ital Cardiol; 1981; 11(7):983-9. PubMed ID: 7308655
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Peripheral vasodilator drugs.
    Br Med J; 1969 Jul; 3(5661):38-40. PubMed ID: 5787285
    [No Abstract]   [Full Text] [Related]  

  • 12. Studies on the effect of alpha- and of beta-adrenergic blocking agents on the circulation in human limbs.
    Clement DL
    Verh K Acad Geneeskd Belg; 1980; 42(3-4):164-214. PubMed ID: 6114601
    [No Abstract]   [Full Text] [Related]  

  • 13. [Clinical experimentation on the tolerance and efficacy of Lamuran administered by phleboclysis in 39 patients with peripheral vascular diseases].
    Dotti GC
    Minerva Med; 1973 May; 64(34):1821-30. PubMed ID: 4719379
    [No Abstract]   [Full Text] [Related]  

  • 14. Evaluation of a new alpha-blocking vasodilator agent (thymoxamine) in peripheral vascular disease.
    Kane SP
    Br J Surg; 1970 Dec; 57(12):921-6. PubMed ID: 4395088
    [No Abstract]   [Full Text] [Related]  

  • 15. [The peripheral blood flow after vasodilatating procedures].
    Landgard H
    Nord Med; 1971 Jun; 85(22):696. PubMed ID: 5088271
    [No Abstract]   [Full Text] [Related]  

  • 16. Thymoxamine (Opilon).
    Drug Ther Bull; 1969 Dec; 7(25):99-100. PubMed ID: 5357789
    [No Abstract]   [Full Text] [Related]  

  • 17. [Vasodilator drugs and obliterating arterial diseases of the lower extremities].
    Larsen OA; Lassen NA
    Ugeskr Laeger; 1967 Sep; 129(36):1168-71. PubMed ID: 5598859
    [No Abstract]   [Full Text] [Related]  

  • 18. [Local treatment of leg disorders and chronic venous insufficiency. Double blind study of 55 patients].
    Widmer LK; Raps E; Glaus L
    Schweiz Rundsch Med Prax; 1972 Oct; 61(42):1300-4. PubMed ID: 4563622
    [No Abstract]   [Full Text] [Related]  

  • 19. The fluorimetric determination of thymoxamine in plasma.
    Arbab AG; Turner P
    J Pharm Pharmacol; 1971 Sep; 23(9):719-21. PubMed ID: 4398259
    [No Abstract]   [Full Text] [Related]  

  • 20. The effect of hydroxyethylrutoside (HR) on peripheral blood flow: a preliminary report.
    Fitzgerald DE; Butterfield WJ; Keates JS; Hodges M
    Bibl Anat; 1969; 10():600-5. PubMed ID: 5407421
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.